Start-up to develop new treatment for heart failure
Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company Mirabilis Therapeutics BV that was founded in 2015.
Mirabilis Therapeutics BV is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases.
For more information on Mirabilis Therapeutics BV, please visit: www.mirabilis-therapeutics.com
Also read
-
Two new academic programmes launch in Venlo
Two programmes, one at Maastricht University and one jointly offered by the universities of Maastricht and Nijmegen, have been given the green light. Both tech and science-based programmes focus on a sustainable world and are part of the Faculty of Science and Engineering. The programmes will start...
-
UM student Natasha Lawrie studies the Bornean elephant: “I only had one week to find them”
Natasha Lawrie, a bachelor’s student from the Maastricht Science Programme, conducted her thesis research in the rainforests of Sabah. There she made surprising discoveries about the feeding habits of the endangered Bornean elephant.
-
More than another ‘to-do’: how the UTQ helped me rethink my teaching
At Maastricht University, the University Teaching Qualification (UTQ) is a professional development programme designed to strengthen teaching and learning. It supports teachers in developing core teaching competencies through a combination of workshops, peer learning, on-the-job experience, and...
